Vaping reforms to protect a new generation from nicotine dependence

8 May 2024


The Pharmaceutical Society of Australia (PSA) joins leading health bodies and the Federal Government in calling for reforms to the sale, supply, manufacture and commercial possession of vapes to pass Parliament.


PSA National President Associate Professor Fei Sim said Australians do not want to see a new generation of Australians taking up smoking or vaping.


“PSA unreservedly supports any measure that reduces the chance of children and young people accessing vapes and support Australia’s world leading approach to tobacco control,” A/Prof Sim said.


“Our priority focus in public health messaging and in policy should continue to be on the harms of cigarette smoking and vaping, particularly to young people and children.


“Ensuring convenience stores do not sell vapes and removing the colours and flavourings that appeal to young people are the first steps to reducing the harm of nicotine vapes.


“There are no nicotine vaping products on the market that have been tested and approved by the Therapeutic Goods Administration as safe therapeutic goods, but there are pathways for vaping products to be used as a genuine smoking cessation tool with the support of healthcare professionals.


“We need to be clear that vaping is not a ‘safe’ alternative to smoking – we’re already seeing scary short-term effects, not to mention the long-term effects that may emerge in the coming years.


“Accessing vaping products through a health professional gives pharmacists the opportunity to provide broader health and smoking cessation support.”


PSA is already assisting government with minimising the impacts of vaping in the community.


A/Prof Sim said: “PSA is supporting pharmacists across Australia with education and training about our role in vaping and smoking cessation.


“There is more work to be done to limit the harm caused by vaping and inhaled nicotine use in general. PSA continues to work with the Federal Government, the Department of Health, the Pharmacy Guild of Australia and other stakeholders to ensure that pharmacists have all necessary resources and education to support vaping reform,” A/Prof Sim concluded.


Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

‘Placement poverty’ affecting future of health sector workforce

6 May 2024


The Pharmaceutical Society of Australia (PSA) is pleased to see the Federal Government taking action to relieve cost of living pressure on students undertaking mandatory unpaid placements as part of their studies but warns that students in pharmacy and other allied health professions are being left behind.


Students studying pharmacy and paramedicine are among thousands who will fall outside of today’s announcement, with unpaid clinical placements forcing some to give up their education altogether.


Under accreditation requirements, pharmacy students are required to undertake clinical placements as part of their course of study.


PSA National President Associate Professor Fei Sim said that the government’s recognition of the strain unpaid placements has on students is the first step, but more needs to be done.


“Clinical placements are a valuable part of the learning experience, but they cannot come at the expense of our student’s livelihoods,” A/Prof Sim says.


“Training the next generation of pharmacists, I see first-hand the pressure unpaid placements put on our students. I’ve seen pharmacy students forced to give up paid work, struggle to make ends meet, and worryingly, drop out of their degrees altogether.


“Many placement sites and pharmacist preceptors also do not get any funding to host placement students.


“Pharmacy students and the pharmacy profession require support to continue to meet the growing future health needs of Australians. We need more people to pick pharmacy as their career choice, and that support must start now.


“All students undertaking compulsory unpaid placements, including pharmacy students, deserve access to government support.


“I urge the Federal Government to revisit this policy and offer the same financial support to all health students who are required to undertake clinical placements as part of their studies.”


National Australian Pharmacy Students Association (NAPSA) President Bano Serhan echoed calls for pharmacy students to have access to support.


“The government has acknowledged that placement poverty deeply affects students, and this is no different for our members,” she says.


“Pharmacy students are being left behind in the budget, at a time when they need more support to build a better and more diverse healthcare workforce.”



PSA contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

NAPSA contact: Sebastian Harper    M: 0437 926 889  E: treasurer@napsa.org.au

CPC24: Nation-leading advocate Brooke Shelly named Credentialed Pharmacist of the Year

3 May 2024




The Pharmaceutical Society of Australia (PSA) is proud to announce the 2024 PSA MIMS Credentialed Pharmacist of the Year, presented at the PSA’s Credentialed Pharmacist Conference (CPC) in Cairns today.


The PSA MIMS Credentialed Pharmacist of the Year award recognises continuing excellence in the practice of credentialed pharmacy, dedication to enhancing the reputation of the profession, the development and implementation of innovative professional services, and the enduring commitment to advancing patient care and improved health outcomes.


The 2024 PSA MIMS Credentialed Pharmacist of the Year is Brooke Shelly MPS.


Ms Brooke Shelly is a passionate advocate for the practice of consultant pharmacy, and in particular the role of pharmacists in rural general practice. She has a growing reputation as an engaging and passionate speaker at conferences, symposiums and other networking and education events, as well as demonstrating her own passion for life-long learning. Her excellence was recognised as a finalist in the 2023 Victorian Rural Health Awards.


Brooke conducts Home Medicines Reviews (HMRs) and is a GP Pharmacist consulting at Ontario Medical Clinic and also has a role as a Clinical Pharmacist at Beyond Pain. She has developed and implemented new multidisciplinary models of care for aged care facilities and chronic disease cycle of care.


Brooke’s commitment to supporting the health of her community and all rural Australians is second to none. She is recognised as a leader in this space, being asked to present at the conferences as a role model for general practice pharmacists, especially in rural Australia. This commitment is evidenced by her leading a workshop at CPC24 to support other pharmacists in optimising outcomes from HMRs and embedded quality improvement activities. Brooke also serves the profession on a range of PSA committees, including on the Victorian Branch Committee and the Board of the Pharmaceutical Society of Victoria.


Ms Shelly’s broad range of innovative services span across general practice, disability services, aboriginal health services, pain management, telehealth and multidisciplinary team-based care significantly enhances the reputation of credentialed pharmacists. She has a particular focus on rural areas of practice, raising awareness on the scope and work of credentialed pharmacist, within the pharmacist community and general practice. Brooke assists in the training of the GP registrars in the CDM space and enjoys overseeing the PIP QI program, making her an invaluable asset to GPs and general practice. She is incredibly generous in sharing her experiences, challenges and innovative solutions in various pharmacist groups, social media and educational events.


Brooke has provided a significant contribution to the development of consultant pharmacy in Australia through her practice in a general practice in a rural area. and as a champion for multidisciplinary care. Brooke is an outstanding role model for pharmacy students, and established and developing practitioners.


PSA National President Associate Professor Fei Sim FPS presented the award to Ms Shelly at CPC24 this afternoon.


“Brooke is a trailblazer when it comes to highlighting the roles of credentialed pharmacists in medication management reviews wherever medicines are used. Brooke’s leadership and contribution has had widespread, systemic impact.,” A/Prof Sim said.


“Brooke is a leading national voice for this workforce, where she continues to make significant contributions to the development of credentialed pharmacy through her own practice and as a mentor and facilitator of discussions and support.


“Over the years, Brooke has been as a strong advocate for interdisciplinary collaboration. Brooke actively facilitates and demonstrates how pharmacists can and should form a critical part of a multidisciplinary team. It is also through her work in this space that she has been able to garner the support and recognition of other health professionals.


“On behalf of the PSA and the profession, I congratulate the 2024 PSA MIMS Credentialed Pharmacist of the Year Brooke Shelly and thank her for her ongoing commitment to the development of credentialed pharmacists across Australia.”


PSA also acknowledges the ongoing support of MIMS Australia and New Zealand, and particularly their CEO and Board Director Robert Best, for sponsoring this award and their ongoing support of the PSA.





Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

CPC24: PSA announces package of support for credentialed pharmacists

3 May 2024


The Pharmaceutical Society of Australia (PSA) has today announced a comprehensive membership package to support credentialed pharmacists through the transition to new credentials, and beyond.


Opening the Credentialed Pharmacist Conference CPC24 in Cairns today, PSA National President Associate Professor Fei Sim FPS announced the full membership package including dedicated resources and support for credentialed pharmacists, as well as dedicated education opportunities to continue developing practice throughout their careers.

This membership offering comes in addition to the announcement of the MMR recognition of prior learning pathway (pending accreditation by the Australian Pharmacy Council), allowing qualified pharmacists to transition to the new credential by completing a short bridging assessment or providing evidence of prior learning.

PSA Professional Plus members will have access to MMR RPL at no cost, and an exclusive discount on RPL for the aged care credential, which is a requirement to practise in the Aged Care On-site Pharmacist program.

“PSA is and always will be the home of credentialed pharmacists,” Associate Professor Fei Sim said.

“PSA has supported accredited pharmacists – soon to be credentialed pharmacists – from day one, advocating for ongoing HMR and RMMR funding, for lifting of caps on services, and for new, funded roles in aged care.


“When AACP closed, PSA chose to invest – rather than divest – in this part of the profession. We continued the tradition of a dedicated conference for accredited pharmacists, now called the Credentialed Pharmacist Conference. We brought on trusted and talented leaders and built a team at the PSA to continue to deliver good work to support our credentialed pharmacist workforce.


“We established in-house accreditation services, a public directory, and are currently undergoing accreditation of our credentialing process for Medication Management Reviews and Aged Care, which is set to recognise the experience of practising consultant pharmacists. I am happy to again confirm that this process will be free-of-charge for PSA Professional Plus members, making the transition more affordable and accessible.


“Professional Plus members also benefit from free access to PSA’s Aged Care Foundations Course – built by some of Australia’s pioneering aged care pharmacists and covering the essential topics for effective practice in aged care.


“In addition to education, PSA’s support for credentialed pharmacists is also growing, including access to PSA’s regular Clinical Update, which is a must-read that helps keep credentialed pharmacists on top of emerging clinical evidence from around the world, as well as discounts to all PSA conferences, including CPC25.


“PSA’s full suite of support is a testament to our commitment to credentialed pharmacists, unmatched by any other organisation at present. I am proud that PSA continues to be the home for credentialed pharmacists.”


Credentialed pharmacists can read more about the offer and PSA’s credentialing process here.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Pharmacists to administer RSV vaccines in QLD

1 May 2024


The Pharmaceutical Society of Australia (PSA) encourages Queensland residents over the age of 60 years to book a respiratory syncytial virus (RSV) vaccine appointment with their local pharmacist, following the addition of the vaccine to the Extended Practice Authority – Pharmacists V5 (EPA) today.

Queensland now joins New South Wales and Victoria as the only jurisdictions in Australia to allow pharmacists to initiate and administer RSV vaccines.

PSA Queensland President Shane MacDonald welcomed the move, saying it was important people protected themselves against infectious diseases ahead of winter.

“We know that older adults with chronic medical conditions including asthma, COPD and diabetes are at an even higher risk of hospitalisation or death because of RSV,” Mr MacDonald said.

“It just makes sense to make the vaccine as accessible as possible, to as many eligible people as possible.

“PSA has been advocating for this vaccine to be added the Extended Practice Authority for some time, and we’re really encouraged see the Queensland Government taking action.”

PSA National President, Associate Professor Fei Sim FPS, called on other Australian jurisdictions to follow lead.

“ATAGI has issued three significant statements about vaccination – for COVID-19, influenza and, for the first time, RSV. Now we have a vaccine that is recommended, it’s important to make sure people can access it from all their regular vaccine providers, including pharmacists.”

RSV vaccines are currently not funded by the National Immunisation Program.

The Australian Technical Advisory Group on Immunisation recommends people over the age of 75 years receive RSV vaccination as well as Aboriginal and Torres Strait Islander people aged over 60 years and those aged over 60 with medical conditions that increase the risk of severe disease due to RSV. All other people over the age of 60 years are also eligible for RSV vaccination.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

MRNs extended for credentialing transition

The Pharmaceutical Society of Australia (PSA) welcomes the extension of Medication Review Numbers (MRNs) to support credentialed pharmacists to continue providing MMR services during the transition to a new credentialing system.

The extension was announced today by the Department of Health and Aged Care Assistant Secretary – Pharmacy Branch, David Laffan, in an email to credentialed pharmacists. The move gives pharmacists 12 months to transition to a new credential, including a Medication Management Review (MMR) credential, and an Aged Care credential.

PSA is set to offer both MMR and Aged Care credentials, as well as offer a pathway for recognition of prior learning to recognise the experience of practising credentialed pharmacists in line with the Accreditation Standards for MMR and Aged Care On-site Pharmacist education programs | Australian Pharmacy Council.

PSA National President Associate Professor Fei Sim FPS said that PSA’s priority and commitment to workforce development have not changed.

“We have been in discussions with the Department for some time to ensure that transition arrangements are in place to minimise disruption to patient services and allow the existing workforce to continue providing MMR services in the immediate term.

“I’m pleased to see action from the Department to allow these services to continue.

A/Prof Sim said that PSA’s credentialing program, which is pending accreditation with the Australian Pharmacy Council, is set to feature ongoing support for credentialed pharmacists and those seeking credentials.

“PSA continues to approach this fast-moving practice area with the intent to support our workforce, and to ensure that the credentialing and recredentialing process is achievable and affordable.

“All pharmacists who have already undergone credentialing will be able to apply for PSA’s recognition of prior learning as part of the new credentialing process.

“PSA is proud to offer further support to members, including offering the new MMR credential to currently credentialed pharmacists with recognition of prior learning at no cost for Professional Plus members.

“This is part of our ongoing support for this workforce, solidifying our place as the home for credentialed pharmacists.”

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Unlocking pharmacist’s potential in the QLD Scope of Practice Pilot

24 April 2024 


Queenslanders are set to have greater access to high-quality, primary healthcare services from today (24 April 2024) under the state government’s Community Pharmacy Scope of Practice Pilot.

Under the Pilot, trained pharmacists will be able to prescribe for a range of common conditions and better support patients with medication management through therapeutic adaptation and substitution and continued dispensing.

PSA Queensland President Shane MacDonald welcomed Health Minister Shannon Fentiman’s announcement today in Cairns.

“The 2020 election commitment to work with PSA, the Pharmacy Guild of Australia, and other stakeholders to implement this Pilot is finally being realised.  It has been a long journey, and we thank the Government for the collaborating with the profession to execute this important work.”

“We must also acknowledge the pioneering pharmacists who, amidst their professional workload and family responsibilities, have dedicated themselves to undertake the extensive education program required to participate.

“Better utilising the skills and accessibility of pharmacists is a great outcome for all Queenslanders,” Mr MacDonald said.

“Queensland is already leading the nation on pharmacist vaccination scope, delivering more vaccines to more patients, and improving vaccine coverage across our state. This is a vote of confidence from the Queensland Government in the skills and expertise of our pharmacists to continue delivering safe and accessible primary health care to Queenslanders.

“On the ten-year anniversary of the Queensland Pharmacist Immunisation Pilot, which led the way on using the pharmacist workforce to vaccinate Australians, the Queensland Government once again is the trail blazer in exploring the benefits of using all health professions to their full scope.

“Empowering pharmacists to manage common acute conditions and better support chronic disease management in community pharmacies is a progressive step towards enhancing healthcare accessibility. Piloting this initiative in Queensland will pave the way for nation-wide impact,” Mr MacDonald concluded.

Queensland PSA Branch Committee member and Pharmacy Partner at LiveLife Pharmacy Macrossan Street (Port Douglas), James Buckley is one of the first pharmacists to complete the training and be authorised to participate.

“I am really excited to be able to support my local community to have better access to care. Pharmacists are so accessible and our pharmacies are open late and on weekends.  It just makes sense to use us to the top of our scope.”


PSA is currently working with the government to become an approved training provider to support the state-wide roll out of the Pilot.


Pilot services

Pharmacists who are approved participate in the Pilot are able to provide additional services that can be grouped into three categories:


Medication management services including therapeutic adaptation, therapeutic substitution and continued dispensing.


Autonomous prescribing for specified acute common conditions and health and wellbeing services: 

  • Gastro-oesophageal reflux and gastro-oesophageal reflux disease
  • Acute nausea and vomiting
  • Allergic and nonallergic rhinitis
  • Impetigo
  • Herpes zoster (shingles)
  • Mild to moderate atopic dermatitis
  • Acute exacerbations of mild plaque psoriasis
  • Mild to moderate acne
  • Acute wound management
  • Acute diffuse otitis externa
  • Acute otitis media
  • Acute mild musculoskeletal pain and inflammation
  • Smoking cessation
  • Hormonal contraception
  • Oral health screening and fluoride application
  • Travel health
  • Management of overweight and obesity


Protocol/structured prescribing as part of a chronic disease management program: 

  • Cardiovascular Disease Risk Reduction Program for type 2 diabetes, hypertension and dyslipidaemia
  • Improved Asthma (and exercise-induced bronchoconstriction) Symptom Program
  • Chronic Obstructive Pulmonary Disease (COPD) Monitoring Program


Consumers interested in learning more can visit Queensland Community Pharmacy Scope of Practice Pilot | Health and wellbeing | Queensland Government (www.qld.gov.au) to find participating pharmacies.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

NIP Vaccination in Pharmacy expansion improves equitable access to vaccines

20 April 2024


The Pharmaceutical Society of Australia (PSA) welcomes the Albanese Government’s expanded funding for National Immunisation Program Vaccination in Pharmacy (NIPVIP) program in aged care and disability homes from 29 April 2024, actioning one of PSA’s key recommendations in its 2024-25 Federal Budget Submission.


Ahead of World Immunisation Week beginning 24 April 2024, the Minister for Health and Aged Care, Hon Mark Butler MP, has announced that pharmacists will be funded to deliver National Immunisation Program vaccines to some of Australia’s most vulnerable priority population groups.


The Minister has also announced that NIPVIP payments will also be indexed in line with Medicare Benefits Schedule (MBS) indexation from 1 July 2024.


PSA Chief Executive Officer, Adjunct Associate Professor Steve Morris welcomed the move, which PSA – as the only peak body representing all of Australia’s 37,000 pharmacists – has been advocating for, to expand access to funded vaccination services to all pharmacists practising in all locations.


“The expansion of the National Immunisation Program Vaccination in Pharmacy program to include pharmacists practising in residential aged care facilities and in disability care will drastically improve the specialised care pharmacists provide to these patients,” Adj. A/Prof Morris said.


“PSA has been supportive of increased investment in pharmacist vaccination services, supporting the delivery of ‘all vaccines, to all ages, in all locations’ – and therefore, pharmacists welcome this announcement.


“It means pharmacists can deliver more services to the priority groups who are the most heavily reliant on vaccines.


“We are continuing to work with governments across Australia on improvements to the accessibility of vaccination services for all Australians ahead of the winter flu season.”


Adj. A/Prof Morris also welcomed the confirmation of service payment indexation in line with indexation of MBS service payments.


“Lifting remuneration to meet the rising costs of service delivery allows pharmacists to continue delivering critical vaccination clinics,” he said.


“Pharmacists continue to be some of the most accessible vaccination providers, supporting increased vaccination coverage around the country. Adequate pharmacist remuneration is critical to ensuring that these essential services delivered by pharmacists can be delivered sustainably, which ultimately protects and maintains equitable access to vaccination services for all Australians.”


Media contact: Georgia Clarke M: 0480 099 798 E: georgia.clarke@psa.org.au


Top West Australian pharmacists recognised

Four outstanding pharmacists have been celebrated this evening as part of the annual Pharmaceutical Society of Australia (PSA) Western Australia Excellence Awards held in Perth.

PSA’s Excellence Awards recognises local pharmacists involved in innovative practice, those who are striving to raise practice standards, and those who, through their professionalism, provide a model of practice which others strive to emulate.

Awards were presented to:

  • Susan Shipway, WA Pharmacist of the Year
  • Maria Luz Ciancia, WA Intern Pharmacist of the Year
  • Jade Swarbrick, WA Early Career Pharmacist of the Year
  • Liza Seubert, WA Lifetime Achievement Award


PSA Western Australia President Kristian Ray MPS congratulated the award recipients.

“Pharmacists are making significant contributions to the health sector, and Western Australia is home to some of the best,” Mr Ray said.

“The pharmacists recognised by the PSA Excellence Awards represent the dedication of great pharmacists. We are proud to recognise them for their ongoing contributions to the profession and to the health of their communities.

“On behalf of PSA and all West Australian pharmacists, congratulations to the 2024 award recipients,” Mr Ray concluded.


Media notes

The WA Pharmacist of the Year is Susan Shipway

Susan Shipway is a hospital pharmacist at Rockingham General Hospital, specialising in oncology and haematology. She recently established a unique pharmacist-led telehealth remote service to patients living in regional Western Australia as part of a PSA partnered non-dispensing pharmacists in general practice heart failure program with the WA Primary Health Alliance.

Sue has strengthened ties between Midwest Aero and Geraldton Hospital and local specialists, having met with the cardiology team at Geraldton Hospital to improve transitions of care. She has initiated heart failure medication optimisation and titration plans to support the GPs within Midwest Aero Medical to ensure patients with heart failure are receiving optimal treatment for their heart failure. She has also developed heart failure fluid balance plans for patients to self-manage their diuretics.

By utilising telehealth to provide heart failure reviews for patients newly discharged, diagnosed or that have previously been identified as living with heart failure, Sue proactively educate patients about the condition. Investigating how the patient is managing by explaining possible and current symptoms and why patients suffer these, is imperative to practising truly patient-centred care.

This is the first time a remote service has been offered to patients living in a regional area, keeping heart failure patients out of hospital by enabling them to manage their condition more effectively.

The WA Intern Pharmacist of the Year is Maria Luz Ciancia

Maria Luz Ciancia spent five years studying pharmacy in Argentina before making the move to Australia. After undertaking exams to revalidate her degree, Maria undertook her internship with Chemist Warehouse in Perth.

At the end of her intern year, Maria developed a mental health campaign to support people suffering from depression in Western Australia. The campaign focused on assessing risk factors, prevention of adverse medication event, and empowering patients to achieve the best practice in medicines management through the implementation of proven and sustainable strategies integrated across all healthcare settings.


The WA Early Career Pharmacist of the Year is Jade Swarbrick

Jade Swarbrick began her pharmacy career as a community pharmacist at Amcal Como after graduating with a Master of Pharmacy in 2018. In 2021 she became credentialed and in 2022 she completed a Graduate Certificate in Clinical Pharmacy at Monash University. Wanting to discover where pharmacy could take her and gain experience in a variety of diverse roles Jade spent time working as a hospital pharmacist at Joondalup Hospital & Northam Hospital, tutoring compounding labs at Curtin University, completing HMRs in community, working in RACFs, and until it’s unfortunate end – working as an educational visitor with NPS MedicineWise.

Since early 2023 Jade has been a GP pharmacist at Mead Medical, as part of the WA Primary Health Alliance non-dispensing pharmacists in general practice program.

She quickly established a pharmacist role at Mead Medical conducting medication reviews as part of chronic disease management appointments; as well as leading several other projects to improve chronic disease management and quality use of medications.

Jade has been recognised in this role as consistently and significantly contributing to improved patient outcomes – and is a highly respected and valued member of the Mead Medical team. She has found her passion in this setting; and is dedicated to advocating for the role of pharmacists in general practice, contributing to the community of practice and helping to mentor pharmacists new to the position.

More recently, Jade has also joined the CoNeCT MHE (Complex Needs Coordination Team – Mental Health Expansion) team as a Care Coordinator. Working with the most frequent emergency department presenters across the Perth-wide hospital services.

Bringing her advanced clinical knowledge, and experience working across the spectrum of healthcare settings she has helped to demonstrate the invaluable role pharmacists can have in multidisciplinary care coordination roles within WA Health.

Between these roles Jade has found her pharmacist niche – providing holistic, patient centred care, optimizing management of patients physical and mental health and advocating for patients experiencing psychosocial barriers to accessing appropriate healthcare.


The WA Lifetime Achievement Award is presented to Associate Professor Liza Seubert FPS

Associate Professor Liza Seubert is a respected figure in the pharmacy profession, earning recognition for her unwavering dedication and transformative contributions. With a career spanning several decades, Liza’s journey began in community pharmacy, moving to the Pharmaceutical Council of Western Australia and Ahpra, and finally to academia at the University of Western Australia.

Throughout her career, Liza’s journey has been marked by innovation and leadership. After establishing herself as a pharmacist, she ventured into ownership and introduced pioneering service delivery models at her pharmacy, setting a precedent for personalised care and medication reviews. Her innovative approach garnered praise, with prominent individuals like Premier Geoff Gallop acknowledging her endeavours.

Liza’s impact extends beyond community pharmacy. Recognizing the importance of education and mentorship, she founded Viva Voce tutoring service, fostering confidence and capability in interns for their final oral exams. Her commitment to education led her to roles at the Pharmaceutical Council of Western Australia with the intern training program and later at the University of Western Australia in the Master of Pharmacy program.

At UWA, Liza’s compassion and commitment to social accountability have distinguished her as a true leader. In her 40’s she embarked on a PhD which researched ways to enhance information exchange during over-the-counter consultations while working full time as an academic. Her research has informed curriculum development and accreditation standards nationwide, with further impact in the new PSA Professional Practice Standards and the updated FIP Global Competency Framework.

She has transformed the learning experience of students in the Master of Pharmacy at UWA with an innovative Courage, Connection and Resilience curriculum to graduate pharmacists with the human skills to thrive in the dynamic and evolving pharmacy profession.

Liza represents the Council of Pharmacy Schools of Australia and New Zealand on the steering committee of the Leaders in Indigenous Pharmacy Profession Education (LIPPE) Network. This network is developing pharmacist education to enable culturally safe pharmacy practice.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA release pharmacist prescribing position statement

15 April 2024


The Pharmaceutical Society of Australia has released its Pharmacist Prescribing position statement, highlighting the growing need for pharmacists to practise to their full and top of scope.


Ahead of the release of the next Scope of Practice Review Issues Paper, PSA clarifies support for pharmacist prescribing through emphasising patient safety and quality practice, and make clear that pharmacists have the required competencies to conduct both prescribing and dispensing.

PSA National President Associate Professor Fei Sim FPS said that regulation should exist to support timely access to medicines, not limit it.

“Pharmacists should not be prevented from helping patients when they need care,” A/Prof Sim said.


“Pharmacists can prescribe medicines within their scope of practice. The red tape and regulation that gets in the way of pharmacists helping patients needs to go.

“Pharmacists currently prescribe within a limited formulary, namely under Continued Dispensing arrangements and Pharmacist-Only medicines, but we have the skills and knowledge to do more.

“Current emergency supply provisions do not adequately mitigate the risks associated with ceasing therapy when a patient cannot access their medicines for a wide range of reasons.

“We need to remove the out-of-date regulatory barriers that get in the way of delivering timely, effective health care.

“We’ve seen in other countries pharmacists are prescribing a wider range of medicines than in Australia. This has been successful in providing safe access to medicines where patients have had trouble accessing other prescribers.

“The emergence of pharmacist prescribing pilots in many Australian jurisdictions is further evidence that pharmacist prescribing is driven by real demand on the ground, and serves to address a gap to improve overall health system capability and capacity.

“We know that the Scope of Practice Review is long, so we have renewed our position statement to meet the evolving health needs of our population.”


The position statement also clearly articulates PSA’s commitment to quality and safety measures for pharmacist prescribing.

”Prescribing and dispensing remain as two discrete clinical activities, and pharmacists’ practice in these two activities will continue to be underpinned by appropriate clinical governance to ensure quality and standards,” A/Prof Sim said.

“This position solidifies our commitment to evidence-based health service delivery.

“PSA strongly believes in the implementation of evaluation and quality frameworks for prescribing services, ensuring that all health service delivery is responsive to the care and therapeutic needs of patients.”

PSA’s Pharmacist Prescribing Position Statement is available here.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au